Clinical outcome measures from trials explained

October 2015, Clinical outcome measures from trials explained by Prof Maria Pia Sormani & Prof Florian Deisenhammer

MARIA PIA SORMANI
Dr Maria Pia Sormani is Professor of Biostatistics at the University of Genoa, Italy. She received her Master in Biostatistics at the University of Milan, her Master in Biophysics at the University of Pisa and her degrees in Physics at the University of Genoa, in Italy. She serves on the National MS Society Clinical Trials Advisory Committee.

FLORIAN DEISENHAMMER
Prof. Florian Deisenhammer is presently Professor of Neurology at the University of Innsbruck in Austria. After graduating in 1989 from the University of Vienna Medical School, he finished training in clinical Neurology at Innsbruck Medical University in 1996 and became senior staff member since then. He is director of the neuroimmunological laboratory and his clinical work focuses on stroke and neuroimmunology, particularly multiple sclerosis. His main scientific interest is MS therapy monitoring, specifically antibodies against interferons and other biomarkers in CSF and blood.

We value your opinion.

How likely are you to recommend this material to a friend or colleague?

Selected Value: 1

Give a score from 1 (= not at all likely) to 10 (extremely likely)

Tell us what you think or ask a question to the expert.

Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.

Email

If you have submitted a question above, leave your email so we can get back to you.

Email are friend

Submit